RxDoctor Payments Data

Mary-Elizabeth Brice

Optometrist · Dunwoody, GANPI 1649411950

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Visioneering Technologies, Inc. accounts for 60.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $4,144 and has fallen 89.4% since, to $438 in 2025. Among optometrist clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,030in general payments, 2019–2025

Across 51 payments — averaging $118.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Visioneering Technologies, Inc.$4K
  • Bausch & Lomb Americas Inc.$738
  • Johnson & Johnson Vision Care, Inc.$736
  • Coopervision Inc.$224
  • Sun Pharmaceutical Industries Inc.$213
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$138
  • plus $313 from 5 others

What the payments were for

  • Food & beverage$6,030100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,030 in reported general payments places this provider in the 90th percentile of 1,285 optometrist providers in Georgia.

See all optometrist providers in Georgia →

Medicare billing

Part B allowed, 2024
$31,089
Medicare patients
197
Services billed
2,046

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone14$621
Timolol Maleate15$181
Latanoprost20$68

Paid to pharmacies, not to this prescriber.

Other optometrist in Dunwoody

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →